A. Beck

A phase 1 study of MDM2 inhibitor DS-3032b in patients with well/de-differentiated liposarcoma (WD/DD LPS), solid tumors (ST) and lymphomas (L).

F. Meric-Bernstam, P. LoRusso, G. Schwartz, 2018 .